204 related articles for article (PubMed ID: 12907906)
1. Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata.
Coremans G; Margaritis V; Snoeck R; Wyndaele J; De Clercq E; Geboes K
Dis Colon Rectum; 2003 Aug; 46(8):1103-8; discussion 1108-9. PubMed ID: 12907906
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of anogenital warts with topical cidofovir].
Fernández-Morano T; Del Boz J; Frieyro-Elichegui M; Repiso JB; Padilla-España L; de Troya-Martín M
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):222-6. PubMed ID: 23182242
[TBL] [Abstract][Full Text] [Related]
3. Topical cidofovir is effective in treating extensive penile condylomata acuminata.
Schürmann D; Bergmann F; Temmesfeld-Wollbrück B; Grobusch MP; Suttorp N
AIDS; 2000 May; 14(8):1075-6. PubMed ID: 10853999
[No Abstract] [Full Text] [Related]
4. Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients.
Orlando G; Fasolo MM; Beretta R; Merli S; Cargnel A
AIDS; 2002 Feb; 16(3):447-50. PubMed ID: 11834957
[TBL] [Abstract][Full Text] [Related]
5. Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.
Martinelli C; Farese A; Mistro AD; Giorgini S; Ruffino I
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):568-9. PubMed ID: 11843219
[TBL] [Abstract][Full Text] [Related]
6. Topical cidofovir for condylomata acuminata of the genitalia in a 3-year-old child.
Calisto D; Arcangeli F
J Am Acad Dermatol; 2003 Dec; 49(6):1192-3. PubMed ID: 14639419
[No Abstract] [Full Text] [Related]
7. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
[No Abstract] [Full Text] [Related]
8. Cidofovir and surgery for genital warts.
TreatmentUpdate; 2002 Feb; 14(2):3-4. PubMed ID: 12691039
[No Abstract] [Full Text] [Related]
9. Local treatment of HPV-induced skin lesions by Cidofovir.
Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
[TBL] [Abstract][Full Text] [Related]
10. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
Toro JR; Sanchez S; Turiansky G; Blauvelt A
Dermatol Clin; 2003 Apr; 21(2):301-9. PubMed ID: 12757253
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of recalcitrant condyloma with topical cidofovir.
Hengge UR; Tietze G
Sex Transm Infect; 2000 Apr; 76(2):143. PubMed ID: 10858720
[No Abstract] [Full Text] [Related]
12. Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
Matteelli A; Beltrame A; Graifemberghi S; Forleo MA; Gulletta M; Ciravolo G; Tedoldi S; Casalini C; Carosi G
Sex Transm Dis; 2001 Jun; 28(6):343-6. PubMed ID: 11403192
[TBL] [Abstract][Full Text] [Related]
13. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
[TBL] [Abstract][Full Text] [Related]
14. Topical use of cidofovir induced acute renal failure.
Bienvenu B; Martinez F; Devergie A; Rybojad M; Rivet J; Bellenger P; Morel P; Gluckman E; Lebbé C
Transplantation; 2002 Feb; 73(4):661-2. PubMed ID: 11889450
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
16. Treatment of anogenital condylomata acuminata with topical photodynamic therapy: report of 14 cases and review.
Nucci V; Torchia D; Cappugi P
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e280-2. PubMed ID: 20346722
[TBL] [Abstract][Full Text] [Related]
17. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Werner RN; Westfechtel L; Dressler C; Nast A
Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
[TBL] [Abstract][Full Text] [Related]
18. [Resolution of recalcitrant condyloma acuminata in a patient with human immunodeficiency virus treated with cidofovir].
Tejera-Vaquerizo A; Bosch-García RJ; Fernández-Orland A; Herrera-Ceballos E
Actas Dermosifiliogr; 2008 Mar; 99(2):162-3. PubMed ID: 18346446
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
